Obstructive Sleep Apnea: The Not-So-Silent Killer.
Obstructive Sleep Apnea: The Not-So-Silent Killer.
复制标题
DOI：
10.1161/circresaha.119.316359
复制
发表时间：
2020-01
影响因子：
20.1
通讯作者：
T. Goodchild;D. Lefer
中科院分区：
文献类型：
--
作者：
T. Goodchild;D. Lefer
因此，肥胖症在普通人群中的患病率正在迅速增加，阻塞性睡眠呼吸暂停的发病率也在迅速增加。麻醉师在治疗诊断为阻塞性睡眠呼吸暂停的患者或表现出阻塞性睡眠呼吸暂停的所有体征和症状的患者时面临重大挑战和风险。在肥胖和阻塞性睡眠呼吸暂停增加的同时，PPM的损失数据反映了涉及阻塞性睡眠呼吸暂停患者的医疗疏忽指控的增加。这些病例通常涉及灾难性的脑损伤或死亡。鉴于阻塞性睡眠呼吸暂停患者所带来的风险增加，投保人经常寻求风险管理建议，以管理这些具有挑战性的患者。
s the prevalence of obesity in the general population is rapidly increasing, so too is the incidence of obstructive sleep apnea. Anesthesiologists face significant challenges and risks when treating patients with diagnosed obstructive sleep apnea or patients who exhibit all the signs and symptoms of obstructive sleep apnea. Concurrent with the increase in obesity and obstructive sleep apnea, PPM’s loss data reflect an increase in allegations of medical negligence involving obstructive sleep apnea patients. These cases often involve catastrophic brain damage or death. In light of the increased risks presented by obstructive sleep apnea patients, policyholders frequently seek risk management advice for managing these challenging patients.